These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

77 related articles for article (PubMed ID: 23044201)

  • 1. [Efficacy of lamivudine on acute-on-chronic liver failure in patients with chronic hepatitis B].
    Xiao L; Qi JH; Shi XF; Sun YC; Yan XZ; Ren H
    Zhonghua Gan Zang Bing Za Zhi; 2012 Jun; 20(6):438-41. PubMed ID: 23044201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influential factors of prognosis in lamivudine treatment for patients with acute-on-chronic hepatitis B liver failure.
    Sun LJ; Yu JW; Zhao YH; Kang P; Li SC
    J Gastroenterol Hepatol; 2010 Mar; 25(3):583-90. PubMed ID: 19968744
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prediction value of model for end-stage liver disease scoring system on prognosis in patients with acute-on-chronic hepatitis B liver failure after plasma exchange and lamivudine treatment.
    Yu JW; Sun LJ; Zhao YH; Li SC
    J Gastroenterol Hepatol; 2008 Aug; 23(8 Pt 1):1242-9. PubMed ID: 18637053
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of telbivudine therapy in liver failure patients with chronic hepatitis B virus infection.
    Wang L; Chen H; Fan C; Gong Z
    J Med Virol; 2013 Nov; 85(11):1907-12. PubMed ID: 23852947
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [The impact of early rapid virological response on the outcomes of hepatitis B associated acute on chronic liver failure during antiviral treatment].
    Chen L; Zheng CX; Lin MH; Gan QR; Lin RS; Gao HB; Huang JR; Pan C
    Zhonghua Gan Zang Bing Za Zhi; 2011 Oct; 19(10):734-7. PubMed ID: 22409843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A multicenter study of lamivudine treatment in 33 patients with hepatitis B after liver transplantation.
    Fontana RJ; Hann HW; Wright T; Everson G; Baker A; Schiff ER; Riely C; Anschuetz G; Riker-Hopkins M; Brown N;
    Liver Transpl; 2001 Jun; 7(6):504-10. PubMed ID: 11443577
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher efficacy of sequential therapy with interferon-alpha and lamivudine combination compared to lamivudine monotherapy in HBeAg positive chronic hepatitis B patients.
    Sarin SK; Kumar M; Kumar R; Kazim SN; Guptan RC; Sakhuja P; Sharma BC
    Am J Gastroenterol; 2005 Nov; 100(11):2463-71. PubMed ID: 16279901
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Tenofovir improves the outcome in patients with spontaneous reactivation of hepatitis B presenting as acute-on-chronic liver failure.
    Garg H; Sarin SK; Kumar M; Garg V; Sharma BC; Kumar A
    Hepatology; 2011 Mar; 53(3):774-80. PubMed ID: 21294143
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Early response to lamivudine therapy in clinically non-cirrhotic chronic hepatitis B patients with decompensation.
    Dai CY; Yu ML; Hsieh MY; Lee LP; Hou NJ; Huang JF; Chen SC; Lin ZY; Hsieh MY; Wang LY; Tsai JF; Chang WY; Chuang WL
    Liver Int; 2007 Dec; 27(10):1364-70. PubMed ID: 17900250
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Entecavir versus lamivudine for patients with HBeAg-negative chronic hepatitis B.
    Lai CL; Shouval D; Lok AS; Chang TT; Cheinquer H; Goodman Z; DeHertogh D; Wilber R; Zink RC; Cross A; Colonno R; Fernandes L;
    N Engl J Med; 2006 Mar; 354(10):1011-20. PubMed ID: 16525138
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Initial combination anti-viral therapy with lamivudine and adefovir dipivoxil decreases short-term fatality rate of hepatitis-B-virus-related acute-on-chronic liver failure.
    Yang J; Chen G; Chen X; Zhang H; Jiang D; Yang G
    Virol J; 2015 Jun; 12():97. PubMed ID: 26104153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lamivudine improves short-term outcome in hepatitis B virus-related acute-on-chronic liver failure patients with a high model for end-stage liver disease score.
    Li X; Gao F; Liu H; Zhang H; Liu Y; Ye X; Geng M; Sun L; Wang R; Li Y; Jiang Y; Wang X; Zhou G; Yang Z; Li A; Zeng H; Wang X
    Eur J Gastroenterol Hepatol; 2017 Jan; 29(1):1-9. PubMed ID: 27749778
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Optimal lamivudine treatment duration and the relationship between its early response and long term effect].
    He YW; Guo CX; Pan YF; Li SL; Wang H
    Zhonghua Gan Zang Bing Za Zhi; 2006 Dec; 14(12):902-5. PubMed ID: 17196133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of entecavir and lamivudine for HBeAg-positive chronic hepatitis B.
    Chang TT; Gish RG; de Man R; Gadano A; Sollano J; Chao YC; Lok AS; Han KH; Goodman Z; Zhu J; Cross A; DeHertogh D; Wilber R; Colonno R; Apelian D;
    N Engl J Med; 2006 Mar; 354(10):1001-10. PubMed ID: 16525137
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [The short-term efficacy of nucleoside analogue on the treatment of acute-on-chronic liver failure].
    Liu XY; Wang HF; Hu JH; He WP; Wang HQ; Liu N
    Zhonghua Gan Zang Bing Za Zhi; 2010 Nov; 18(11):845-8. PubMed ID: 21138634
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prediction of prognosis to lamivudine in patients with spontaneous reactivation of hepatitis B virus-related acute-on-chronic liver failure: using virologic response at week 4.
    Xiang-Hui Y; Lang X; Yan Z; Li Z; Xiao-Feng S; Hong R
    Eur J Intern Med; 2014 Nov; 25(9):860-4. PubMed ID: 25439100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evolutionary patterns of hepatitis B virus quasispecies under different selective pressures: correlation with antiviral efficacy.
    Liu F; Chen L; Yu DM; Deng L; Chen R; Jiang Y; Chen L; Huang SY; Yu JL; Gong QM; Zhang XX
    Gut; 2011 Sep; 60(9):1269-77. PubMed ID: 21292683
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early mortality in Taiwanese lamivudine-treated patients with chronic hepatitis B-related decompensation: evaluation of the model for end-stage liver disease and index scoring systems as prognostic predictors.
    Dai CY; Chuang WL; Hou NJ; Lee LP; Hsieh MY; Lin ZY; Chen SC; Huang JF; Hsieh MY; Wang LY; Tsai JF; Wen-Yu ; Yu ML
    Clin Ther; 2006 Dec; 28(12):2081-92. PubMed ID: 17296464
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Long-term effect of lamivudine treatment in chronic hepatitis B virus infection].
    Yao G; Wang B; Cui Z
    Zhonghua Gan Zang Bing Za Zhi; 1999 Jun; 7(2):80-3. PubMed ID: 10488413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term follow-up of lamivudine treatment in patients with severe acute exacerbation of hepatitis B e antigen (HBeAg)-positive chronic hepatitis B.
    Wong VW; Wong GL; Tsang SW; Hui AY; Chim AM; Yiu KK; Chan HY; Chan FK; Sung JJ; Chan HL
    Antivir Ther; 2008; 13(4):571-9. PubMed ID: 18672536
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.